|
C4ORF3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.855600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.982000E-04 |
| Normal-vs-Stage2 |
7.991400E-01 |
| Normal-vs-Stage3 |
8.118300E-03 |
| Normal-vs-Stage4 |
4.41399999999703E-05 |
| Stage1-vs-Stage2 |
2.928300E-02 |
| Stage1-vs-Stage3 |
3.07300000002009E-07 |
| Stage1-vs-Stage4 |
1.11149978110348E-10 |
| Stage2-vs-Stage3 |
1.566230E-01 |
| Stage2-vs-Stage4 |
2.741800E-02 |
| Stage3-vs-Stage4 |
2.201600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.719600E-01 |
| Normal-vs-AfricanAmerican |
2.278800E-01 |
| Normal-vs-Asian |
4.600000E-01 |
| Caucasian-vs-AfricanAmerican |
2.027000E-01 |
| Caucasian-vs-Asian |
4.377600E-01 |
| AfricanAmerican-vs-Asian |
2.578200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.217600E-01 |
| Normal-vs-Female |
5.021900E-02 |
| Male-vs-Female |
5.739400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.651600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.247800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.544000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.173000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.267600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.411200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.741000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.164600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.065200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.784800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.382200E-03 |
| Normal-vs-Grade 2 |
1.418770E-04 |
| Normal-vs-Grade 3 |
2.780500E-02 |
| Normal-vs-Grade 4 |
5.14669999951423E-07 |
| Grade 1-vs-Grade 2 |
1.481800E-01 |
| Grade 1-vs-Grade 3 |
1.025360E-04 |
| Grade 1-vs-Grade 4 |
2.2654999987104E-08 |
| Grade 2-vs-Grade 3 |
5.42550000481867E-08 |
| Grade 2-vs-Grade 4 |
6.80233647187833E-13 |
| Grade 3-vs-Grade 4 |
4.156400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.70899999998964E-06 |
| Normal-vs-ccB subtype |
3.983900E-03 |
| ccA subtype-vs-ccB subtype |
2.1522994497758E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.843000E-01 |
| Normal-vs-N1 |
6.336500E-02 |
| N0-vs-N1 |
5.811700E-02 |
|
|
